TAPSE/RVSP ratio as an echocardiographic marker of residual risk in HFrEF patients receiving vericiguat

11 December 2025 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: Understanding the pathophysiology of heart failure Imaging of Heart Failure EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)